Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 50 mcg tablets nationwide because they may contain less than the labeled amount of active ingredient.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly states the agency classification is 'Class II'. According to the severity rubric, an FDA Class II recall corresponds to a score of 4 (Severe), as the rule states that if the agency's own classification is FDA Class I or USDA Class I, the score is never below 4, and Class II is the next tier down which maps to Severe in the provided mapping context for significant drug issues.
Plain-English summary
Accord Healthcare, Inc. is voluntarily recalling Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles. The recall is initiated because the affected drug products are subpotent, meaning they may contain less than the labeled amount of the active ingredient. The specific lots involved are D2401834 and D2401982 (expiration date 08/31/2026) and D2402584, D2402585, D2402586, D2402588, D2402587, and D2402589 (expiration date 11/30/2026). The products were distributed nationwide within the United States.
The FDA has classified this recall as Class II, which indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. The recall was initiated by the firm on August 6, 2026, and the status is ongoing.
Patients taking these specific lots of Levothyroxine Sodium should contact their healthcare provider for guidance. The recall is voluntary and was initiated by Accord Healthcare, Inc.
The recalled product
- Product
- LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
- Brand
- LEVOTHYROXINE SODIUM
- Manufacturer
- ACCORD HEALTHCARE, INC.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: D2401834
- D2401982
- Exp. Date 08/31/2026
- D2402584
- D2402585
- D2402586
- D2402588
- D2402587
- D2402589
- Exp Date. 11/30/2026.
UPCs (12)
- 0316729447157
- 0316729449151
- 0316729452151
- 0316729454155
- 0316729453158
- 0316729448154
- 0316729451154
- 0316729457156
- 0316729450157
- 0316729456159
- 0316729458153
- 0316729455152
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LEVOTHYROXINE SODIUM
- SevereAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
Same manufacturer · ACCORD HEALTHCARE, INC.
See all →- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02